Specifically, evaluation of MMR proteins expression is useful not only for a proper risk group classification but also in selecting patients who possibly need screening for Lynch syndrome, while assessment of p53 may be useful for diagnostic purposes (i.e., histotype) and to identify higher risk cases. This evidence concerns the gene MRC1 and Lynch syndrome.